Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTOG 0418: Pelvic IMRT for Post-Operative Endometrial or Cervical Cancer
NCT00331760Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Mar 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label trial of cisplatin in Cervical Cancer (CC) and endometrial cancer (EC), sponsored by NRG Oncology. Started Mar 2006; status: completed.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00331760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331760.